Free DHL shipping
CE Marking: Yes
Medytox
Neuramis® Volume Lidocaine 1 x 1ml
Description
Short Description
Article: Neuramis® Volume Lidocaine
Manufacturer: Medytox
Concentration: 20 mg/ml
Package contents: 1 x 1ml
Needle/cannulas: 2 x 27G ½
Quantity:
Choose options
Description
Short Description
Article: Neuramis® Volume Lidocaine
Manufacturer: Medytox
Concentration: 20 mg/ml
Package contents: 1 x 1ml
Needle/cannulas: 2 x 27G ½
Quantity:
Description
Short Description
Article: Neuramis® Volume Lidocaine
Manufacturer: Medytox
Concentration: 20 mg/ml
Package contents: 1 x 1ml
Needle/cannulas: 2 x 27G ½
Quantity:
Neuramis® Volume Lidocaine
Neuramis Volume Lidocaine is a high-quality dermal filler designed to restore facial volume loss and correct deep wrinkles. It is part of the Neuramis product line from Medytox, a leading company in the biopharmaceutical industry. This product combines cross-linked hyaluronic acid with lidocaine, a local anesthetic, to provide a comfortable and effective treatment.
Neuramis Volume Lidocaine contains cross-linked hyaluronic acid, which is produced using the innovative SHAPE™ technology. This technology ensures uniform particle size and high purity of the gel, minimizing the risk of side effects and maximizing the longevity of the results. The product also contains 0.3% lidocaine, making the injection process nearly pain-free.
AREAS OF APPLICATION
- Cheek augmentation
- Chin and jawline contour
- Nasolabial folds
- Deep wrinkles and lines
These features make Neuramis® Volume Lidocaine unique
- Long-lasting results: The advanced cross-linking technology provides results that last up to 12 months.
- High comfort: The included lidocaine ensures a pain-free treatment and enhances the patient experience.
- Safety and purity: The manufacturing method guarantees high purity and biocompatibility, minimizing the risk of allergic reactions and side effects.
- Easy and even application: The smooth gel texture allows for precise injections and natural results.
Medytox
Medytox is a globally leading biopharmaceutical company, known for its innovative research and development. Since the introduction of Botulinum toxin type A Meditoxin® in 2006, Medytox has experienced strong growth, holding nearly 40% market share in Korea since 2009.
Herstellerinformationen anzeigen
Before you
get started
Some items in our range are subject to the Medical Device Act. Please let us know before your purchase if you are a private customer or a professional user (doctors, alternative practitioners, pharmacists, or wholesalers).